abrdn plc purchased a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 100,912 shares of the company's stock, valued at approximately $7,847,000. abrdn plc owned about 0.11% of Acadia Healthcare at the end of the most recent reporting period.
Several other hedge funds have also added to or reduced their stakes in ACHC. Vaughan Nelson Investment Management L.P. acquired a new stake in Acadia Healthcare during the 4th quarter valued at $24,157,000. OFI Invest Asset Management lifted its holdings in shares of Acadia Healthcare by 290.5% during the third quarter. OFI Invest Asset Management now owns 331,129 shares of the company's stock worth $21,990,000 after buying an additional 246,322 shares in the last quarter. California Public Employees Retirement System lifted its holdings in shares of Acadia Healthcare by 112.6% during the third quarter. California Public Employees Retirement System now owns 368,382 shares of the company's stock worth $25,901,000 after buying an additional 195,130 shares in the last quarter. Kingdon Capital Management L.L.C. acquired a new stake in shares of Acadia Healthcare during the third quarter worth $12,058,000. Finally, Avidity Partners Management LP lifted its holdings in shares of Acadia Healthcare by 30.0% during the third quarter. Avidity Partners Management LP now owns 715,000 shares of the company's stock worth $50,272,000 after buying an additional 165,000 shares in the last quarter.
Wall Street Analysts Forecast Growth
ACHC has been the subject of a number of research reports. UBS Group lifted their target price on Acadia Healthcare from $88.00 to $102.00 and gave the stock a "buy" rating in a report on Wednesday, February 28th. Stephens raised Acadia Healthcare from an "equal weight" rating to an "overweight" rating and set a $92.00 target price for the company in a report on Friday, January 5th. Mizuho lifted their target price on Acadia Healthcare from $77.00 to $84.00 and gave the stock a "neutral" rating in a report on Wednesday, March 6th. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a "sell" rating to a "hold" rating and set a $70.00 target price for the company in a report on Thursday. Finally, Barclays began coverage on Acadia Healthcare in a report on Wednesday, March 6th. They set an "overweight" rating and a $100.00 target price for the company. Four research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $92.00.
Get Our Latest Research Report on Acadia Healthcare
Acadia Healthcare Price Performance
ACHC stock traded up $0.21 during midday trading on Friday, reaching $73.59. The company had a trading volume of 689,372 shares, compared to its average volume of 543,881. Acadia Healthcare Company, Inc. has a 1-year low of $66.49 and a 1-year high of $87.77. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.67 and a quick ratio of 0.67. The stock has a 50 day moving average price of $78.07 and a 200-day moving average price of $77.70. The company has a market capitalization of $6.80 billion, a price-to-earnings ratio of -294.35, a price-to-earnings-growth ratio of 2.17 and a beta of 1.31.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.80 by $0.05. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The firm had revenue of $742.80 million for the quarter, compared to analysts' expectations of $727.60 million. During the same quarter in the previous year, the business posted $0.70 earnings per share. The business's revenue for the quarter was up 10.0% on a year-over-year basis. Equities research analysts expect that Acadia Healthcare Company, Inc. will post 3.57 earnings per share for the current year.
Insider Buying and Selling at Acadia Healthcare
In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now owns 46,074 shares in the company, valued at $3,934,258.86. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 2.80% of the company's stock.
About Acadia Healthcare
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Read More
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
